Fake Dharwad Pedha in the Market.

A sweet delicacy of Karnataka , The ‘Dharwad Pedha’ (80) may have acquired a Geographical Indication (GI) tag since 2008, but bakeries and sweetmeat shops across Bangalore have been selling pedhas using the brand name ‘Dharwad’. It is a well known fact that, once a GI tag is obtained to a product, it is mandatory…

Thomson Reuters’ India Innovation Awards 2014

Biocon and Sun Pharma were honored recently at Thomson Reuters’ India Innovation Awards 2014. This is the second consecutive year of the study of State of Innovation India Report, which analyses innovation in 12 leading sectors, which are based on patent activity for inventions originating from India, using the Derwent World Patents Index- A Thomson…

Varanasi Glass Beads to get GI Recognition

Glass beads in various types, a handicraft that originated in the rural areas of Varanasi, also called as “kaanch ke moti” soon to receive a geographical indication status.  According to reports the Geographical Indication (GI) Registry of India has agreed to certify this handicraft which comprises earrings, bracelets and necklaces made of glass beads. The…

DU to set up Intellectual Property Facilitation Centre

The University of Delhi (DU) recently announced that it is coming up with a new intellectual property rights (IPR) policy under which it will create an Intellectual Property Facilitation Centre (IPFC) for micro, small and medium enterprises (MSMEs) at the Cluster Innovation Centre (CIC). The university is taking this step to ensure that awareness is…

Row over KSRTC Trademark

The Kerala State Road Transport Corporation (KSRTC) and its Karnataka equivalent are in a trademark row over the mark “KSRTC”, as both are identified with the same acronym. The Karnataka State Road Transport Corporation has requested Kerala to refrain from using the name KSRTC after obtaining a trademark on the name from the Trade Marks…

AbbVie signs agreement and adds children’s AIDS drugs to shared patent pool

AbbVie,  a research-based bio pharmaceutical company from the US has signed a Licensing Agreement for HIV Paediatric Formulations of Lopinavir (LPV) and Ritonavir (r) with the Medicines Patent Pool (MPP) on World AIDS Day. The license agreement will enable others to re-formulate and manufacture specially designed LPV/r and r paediatric treatments for distribution in the developing world…